Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 2,021 shares at $58.86 ($114K) on 2020-01-22, disclosed to the SEC on 2020-01-24.
Scheduled sale ($114k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.97 | 500 | $27K | 24.1% |
| 2 | $55.99 | 500 | $28K | 24.5% |
| 3 | $56.99 | 671 | $38K | 33.5% |
| 4 | $58.00 | 200 | $12K | 10.2% |
| 5 | $58.86 | 150 | $9K | 7.7% |
| Total | $56.48 avg | 2,021 |
| $114K |
| 100% |
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-10 | $1.7M | — | Filing → |
| BHVN | SELL | 2019-12-18 | $390K | — | Filing → |